Sr. Research Coordinator Resume Example

Highly motivated and skilled  researcher with basic , translational and clinical research experience in human health and diseases seeking scientific career to contribute to better clinical outcomes.

• Clinical Procedures: Phlebotomy, vital sign measurements, ECG/EKG.
• EDC : REDCAP; Inform; IBM;
• EMR: CPRS; EPIC
• Research Methods: Processing human blood samples, separation of
  plasma/serum, peripheral blood mononuclear cells isolation and platelet cell
  preparation, record keeping for patient data.
  Cell culture;  Gel electrophoresis, Western blot analysis, Pull down assays, Protein-binding assays, Enzyme- linked immunosorbent assay (ELISA)
  Lipid isolation: Thin layer chromatography (TLC), Immuno-TLC colorimetric
  assays.Flow cytometry and cell sorting (FACS):Cell- base assays for viability, apoptosis and proliferation . Assay development for high throughput drug screening.Microscopy: Immunostaining and Immunofluorescence microscopy (IF), Confocal microscopy, electron microscopy, Fluorescent in situ hybridization (FISH). Molecular Biology techniques: DNA, RNA Isolation and quantification, Plasmid Purification, Agarose gel electrophoresis, PCR, Real time PCR.
  Animal handling: mouse and rat colony maintenance, animal procedures:
  genotyping, oral gavage, collection of blood and all other tissue harvesting, necropsy, tissue sectioning etc.
• Software: Microsoft Office, Adobe Photoshop, Graph Pad Prism, Flow analysis software; Image J software.

 Organized; Ability to manage competing priorities; Strong interpersonal skills, Multilingual.

Book Chapter:
Mukherjee K, Chowdhury 5, Mondal S, Mandal C, Chandra S and Mandal C. (2007) 9-O-Acetyl GD3 in lymphoid and erythroid cells. Molecular Immunology of Complex Carbohydrates 3, Pp317-334, Albert M Wu Editor, (SPRINGER).
Journals:
1. Mukherjee K, Chava A.K, Bandyopadhyay 5, Mallick A, Chandra S and Mandal C.
Co- expression of 9-0-acetylated sialoglycoproteins (Neu5,9Ac2GPs) and their binding proteins (BPs) on lymphoblasts of childhood acute lymphoblastic leukaemia (ALL) : an anti-apoptotic role. Biological Chemistry 2009, 390:325-335.
2. Mukherjee K, Chava AK, Dey S.N, Kniep B, Chandra 5, Mandal C. 0-acetylation of GD3 prevents its apoptotic effect and promotes survival of lymphoblasts in childhood acute lymphoblastic leukaemia J Cell Biochem. 2008, 105:724-734.
3. Mukherjee K, Chowdhury 5, Mondal 5, Mandal C, Chandra 5, Bhadra RK, Mandal
C.9-0-acetylated GD3 triggers programmed cell death in mature erythrocytes. Biochem Biophys Res Commun. 2007, 362(3): 651-657.
4. Ghosh 5, Bandyopadhyay S. Mukherjee K, Mallick A, Pal S, Mandal C, Bhattacharya DK, Mandal C.0-acetylation of sialic acids is required for the survival of lymphoblasts in childhood acute lymphoblastic leukemia (ALL).Glycoconj J. 2007 24(1):17-24.
5. Bandyopadhyay 5, Mukherjee K, Chatteilee M, Bhattacharya DK, Mandal C.
Detection of immune-complexed 9-0-acetylated sialoglycoconjugates in the sera of patients.
Conference Presentations
1. Mukherjee K, Chava A.K, Bandyopadhyay S, Mallik A, Chandra S and Mandal C. Cell surface receptors, for 9-0-acetylated sialoglycoproteins on lymphoblasts of children with acute lymphoblastic leukemia. 7th International Symposium on
Biochemical Roles of Eukaryotic Cell Surface Macromolecules, Pun, 10 -14 th Jan 2005, India.
2. Mukherjee K. Biological role of newly induced 9-0-acetylated sialoglycoproteins in
survival of lymphoblasts of childhood acute leukemia. DBT-NCBS Cancer Meet, Bangalore, August 6-7,2005, India.
3. Mukherjee K, Chowdhury S, Mondal 5, Mandal C, Chandra 5, and Mandal C.9-0-acetylated GD3 in leukemia. (Oral). International Symposium on Molecular Immunology of Complex Carbohydrates-3, Taiwan, 8-12th July, 2007.